Haslehurst et al. found that inhibition of SLUG largely reversed the mesenchymal phenotype of ovarian cancer cells, markedly weakened the ability of cell migration and invasion, and resensitized cells to cisplatin treatment [21]. Here, SNAI2 is linked to ovarian carcinoma.